Nutrients and amyloid β status in the brain: A narrative review
Nov 1, 2022 · In contrast, higher HDL levels and a higher concentration of polyunsaturated triglycerides (PUTG) was associated to increased Aβ42 blood levels (Bernath et al., 2020) (Table 2).
UC study: Alzheimer’s drug may work by boosting brain protein levels ...
Sep 11, 2024 · A study led by University of Cincinnati researchers found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of the protein Aβ42 in …
High-Intensity Physical Activity Modulates Diet Effects on ...
Importantly, diet effects on this AD biomarker differed for normal and MCI groups. For normals, CSF Aβ42 levels were reduced with the LOW diet but increased with the HIGH diet. In MCI, the reverse …
Alzheimer's decline may be slowed by protein boost - Newsweek
Sep 11, 2024 · What they found was that higher levels of Aβ42 after treatment were associated with slower cognitive decline. "All stories have two sides—even the one we have told ourselves about how...
Alzheimer's: Boosting brain protein may slow cognitive decline
Sep 18, 2024 · After analyzing the study data, researchers discovered that higher levels of Aβ42 after monoclonal antibody treatment were independently associated with slower cognitive impairment and...
Boosting brain protein levels may slow decline from Alzheimer’s
Sep 11, 2024 · They found that higher levels of Aβ42 after treatment were independently associated with slower cognitive impairment and clinical decline. “All stories have two sides — even the one we …
New Drugs Fight Alzheimer’s by Increasing Amyloid Beta & Reducing ...
Sep 23, 2024 · How do the new drugs Leqembi and Kisunla fight Alzheimer's? Surprisingly, increases in amyloid-beta protein levels can explain the slowing of Alzheimer's at least as well as the reduction in …
Boosting Brain Protein May Slow Alzheimer’s Decline
Oct 15, 2024 · Higher levels of amyloid-beta are associated with slower cognitive deterioration. Researchers analyzed the study data and found that slower cognitive impairment and clinical decline …
Rethinking Alzheimer's: Increasing Amyloid-β42 Slows Disease ...
Sep 18, 2024 · These results highlight the need to explore therapies that directly raise Aβ42 levels without targeting amyloid plaques, providing a fresh perspective on Alzheimer’s treatment.
A New Breakthrough in Alzheimer’s Disease: How Amyloid-Beta 42 …
Jan 10, 2025 · While high levels in the brain are harmful, recent studies suggest that increasing CSF Aβ42 levels may actually help slow cognitive decline by promoting the clearance of these plaques.